Mucinac AB Tablet is a prescription medication for treating chronic obstructive pulmonary disease (COPD) and bronchial asthma.
COPD is a chronic lung disease that typically progresses over time. It is characterised by persistent airflow limitation. Other symptoms of COPD include persistent coughing with mucus production, shortness of breath, especially during physical activity, wheezing or noisy breathing and chest tightness.
Bronchial asthma is a chronic condition that affects the airways, causing inflammation and narrowing. It leads to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing.
The common triggers for asthma attacks include allergies, exercise, respiratory infections, and exposure to irritants such as smoke or pollutants.
This tablet helps to relax the muscles in the airways and reduce inflammation. It also alleviates coughing, wheezing, making it easier to breathe. The composition of Mucinac AB Tablet includes two active ingredients: acebrophylline (100 mg) and acetylcysteine (600 mg).